Panacea Biotec, India's leading vaccine manufacturer has inaugurated its new state-of-the-art Oncology facility at Baddi in Himachal Pradesh to meet the growing demand of anti-cancer products in the country.
The new manufacturing facility will entail an annual production of about 1.2 million vials, and being set up in compliance with various international regulatory standards like CGMP, USFDA and UK-MHRA. The plant has been set up with a project cost of about Rs 55 crore.
The company has been aggressively ramping up its production capacity, as well as introducing new business lines to cater to emerging business opportunities in various therapeutic segments. The company has released products for sales from commercial production from March 2012.
Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: